MSLN and pachyonychia congenita: Mesothelin (MSLN), a cell–surface glycoprotein, is a tumor-differentiation antigen that is highly expressed in mesothelioma (MPM), lung cancer, PC, and ovarian cancer.96–99 However, it is also expressed normally in the pleura, pericardium, and peritoneum mesothelial cells.100